Daniel E. Lopes de Menezes
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 5
-
- Lipid Membrane Structure and Behavior 4
- Cancer therapeutics and mechanisms 2
- RNA Interference and Gene Delivery 2
- Synthesis and bioactivity of alkaloids 1
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Theresa M. AllenChristian HansenLinda M. PilarskiSamuel ZalipskyElaine H. MoaseMarc KirchmeierIsrar AhmadLawrence D. Mayer
- Journals
- Cancer Research (1 paper)Advanced Drug Delivery Reviews (1 paper)Clinical Cancer Research (2 papers)
- Partner nations
- CanadaUnited StatesIndia
In The Last Decade
Daniel E. Lopes de Menezes
12 papers receiving 707 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 253
- Molecular Biology 489
- Pharmaceutical Science 39
- Oncology 173
- Hematology 54
Countries citing papers authored by Daniel E. Lopes de Menezes
This map shows the geographic impact of Daniel E. Lopes de Menezes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Lopes de Menezes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Lopes de Menezes more than expected).
Fields of papers citing papers by Daniel E. Lopes de Menezes
This network shows the impact of papers produced by Daniel E. Lopes de Menezes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Lopes de Menezes. The network helps show where Daniel E. Lopes de Menezes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel E. Lopes de Menezes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 117 | |
| 2 | 2006 | 22 | |
| 3 | Multitargeted kinase inhibition and sustained biological effects of CHIR-258 contribute to enhanced preclinical efficacy | 2005 | 1 |
| 4 | 2005 | 95 | |
| 5 | 2003 | 20 | |
| 6 | 2000 | 40 | |
| 7 | 2000 | 21 | |
| 8 | 1999 | 62 | |
| 9 | 1996 | 63 | |
| 10 | 1996 | 4 | |
| 11 | 1995 | 245 | |
| 12 | 1995 | 48 |
About Daniel E. Lopes de Menezes
Daniel E. Lopes de Menezes is a scholar working on Biomaterials, Pharmaceutical Science and Hematology, having authored 12 papers that have together received 738 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Lipid Membrane Structure and Behavior (4 papers), Cancer therapeutics and mechanisms (2 papers), Drug Transport and Resistance Mechanisms (2 papers), RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advanced Drug Delivery Systems (2 papers) and Synthesis and bioactivity of alkaloids (1 paper). The work is most often cited by research in Biomaterials (253 citations), Molecular Biology (489 citations) and Pharmaceutical Science (39 citations). Daniel E. Lopes de Menezes has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Theresa M. Allen, Christian Hansen, Linda M. Pilarski, Samuel Zalipsky, Elaine H. Moase, Marc Kirchmeier, Israr Ahmad, Lawrence D. Mayer, Andrew R. Belch and Katherine G. Rendahl. Their work appears in journals such as Cancer Research, Advanced Drug Delivery Reviews and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.